Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer (Q40111302)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer |
scientific article |
Statements
1 reference
Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer (English)
1 reference
Hiroyuki Saeki
1 reference
Shunsuke Yanoma
1 reference
Shouji Takemiya
1 reference
Yukio Sugimasa
1 reference
Makoto Akaike
1 reference
Norio Yukawa
1 reference
Yasushi Rino
1 reference
Toshio Imada
1 reference
1 August 2007
1 reference
1 reference